Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.

Simvastatin and MS: The Lancet Neurology: August 2017

The Lancet Neurology is a monthly journal, renowned for the publication of high-quality peer-reviewed research, reviews, and analysis from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue, with occasional interviews with an author of a key article.

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Education

Training

Language Courses

Higher Education

K-12

Educational Technology

Health

Alternative Health

Self-Help

Sexuality

Fitness & Nutrition

Brent Fogel talks to The Lancet Neurology about his work on large-scale genomic analysis.

Next-generation sequencing and clinical neurology

Amaia Arranz and Bart De Strooper discuss their Review on the role of astroglia in Alzheimer's disease.

Role of astroglia in Alzheimer's disease

Michael Irwin (University of California, Los Angeles, USA) discusses a Review concerning potential links of sleep disturbance and possible increased risk of Alzheimer's disease dementia.

Sleep disturbance and dementia risk

Lindsay Wallace and Kenneth Rockwood join The Lancet Neurology to talk about their work on the association between frailty and the onset of Alzheimer's disease.

Frailty and Alzheimer's

In the latest podcast from The Lancet Neurology, Jan Scheitz discusses the development of stroke–heart syndrome.

Simvastatin and MS: The Lancet Neurology: August 2017

Download our free app to listen on your phone